Dana-Farber Cancer Institute's Molecular Biology Core Facilities Integrate n6 iconPCR into Low-Input cfDNA Sequencing Service

Markets PR Newswire By PR Newswire 13 Nov 2026 17:53 1 min read
Dana-Farber Cancer Institute's Molecular Biology Core Facilities Integrate n6 iconPCR into Low-Input cfDNA Sequencing Service

Integrated workflow reduced library-yield variability, enabled mixed-input processing, and supported reliable 0.5% allele-frequency detection from 1 ng in reference-standard testing PLEASANTON, Calif., Nov. 13, 2026 /PRNewswire/ -- n6 Tec, Inc. (n6), developer of iconPCR™ systems with...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.